Improve Access to Care for Opioid Use Disorder: A Call to Eliminate the X-Waiver Requirement Now

doi:10.1016/j.annemergmed.2021.03.023

Editorial

. 2021 Aug;78(2):220-222.

doi: 10.1016/j.annemergmed.2021.03.023. Epub 2021 May 7.

Improve Access to Care for Opioid Use Disorder: A Call to Eliminate the X-Waiver Requirement Now

Gail D'Onofrio¹, Edward R Melnick², Kathryn F Hawk²

Affiliations

¹ Department of Emergency Medicine, Yale School of Medicine, New Haven, CT. Electronic address: gail.donofrio@yale.edu.
² Department of Emergency Medicine, Yale School of Medicine, New Haven, CT.

PMID: 33966933
PMCID: PMC8324519
DOI: 10.1016/j.annemergmed.2021.03.023

Editorial

Improve Access to Care for Opioid Use Disorder: A Call to Eliminate the X-Waiver Requirement Now

Gail D'Onofrio et al. Ann Emerg Med. 2021 Aug.

. 2021 Aug;78(2):220-222.

doi: 10.1016/j.annemergmed.2021.03.023. Epub 2021 May 7.

Authors

Gail D'Onofrio¹, Edward R Melnick², Kathryn F Hawk²

Affiliations

¹ Department of Emergency Medicine, Yale School of Medicine, New Haven, CT. Electronic address: gail.donofrio@yale.edu.
² Department of Emergency Medicine, Yale School of Medicine, New Haven, CT.

PMID: 33966933
PMCID: PMC8324519
DOI: 10.1016/j.annemergmed.2021.03.023

No abstract available

PubMed Disclaimer

Comment in

Challenges in Treating Opioid Use Disorder Beyond the Waiver.
Akhter M, Fernandez Dunham E. Akhter M, et al. Ann Emerg Med. 2022 Feb;79(2):218-219. doi: 10.1016/j.annemergmed.2021.10.014. Ann Emerg Med. 2022. PMID: 35065745 No abstract available.
In reply.
D'Onofrio G, Melnick ER, Hawk KF. D'Onofrio G, et al. Ann Emerg Med. 2022 Feb;79(2):219-220. doi: 10.1016/j.annemergmed.2021.10.022. Ann Emerg Med. 2022. PMID: 35065746 No abstract available.

Cited by

The potential impact of clinical decision support on nonwaivered primary care clinicians' prescribing of buprenorphine.
Olson AW, Haapala JL, Hooker SA, Solberg LI, Borgert-Spaniol CM, Romagnoli KM, Allen CI, Tusing LD, Wright EA, Haller IV, Rossom RC. Olson AW, et al. Health Aff Sch. 2023 Oct 11;1(4):qxad051. doi: 10.1093/haschl/qxad051. eCollection 2023 Oct. Health Aff Sch. 2023. PMID: 38756745 Free PMC article.
Substance Use Treatment Utilization Among Women With and Without Human Immunodeficiency Virus.
Fujita AW, Ramakrishnan A, Mehta CC, Yusuf OB, Wilson T, Shoptaw S, Carrico AW, Adimora AA, Eaton E, Cohen MH, Cohen J, Adedimeji A, Plankey M, Jones D, Chandran A, Colasanti JA, Sheth AN. Fujita AW, et al. Open Forum Infect Dis. 2022 Dec 21;10(1):ofac684. doi: 10.1093/ofid/ofac684. eCollection 2023 Jan. Open Forum Infect Dis. 2022. PMID: 36655189 Free PMC article.
Buprenorphine treatment episode duration, dosage, and concurrent prescribing of benzodiazepines and opioid analgesics: The effects of Medicaid prior authorization policies.
Landis RK, Opper I, Saloner B, Gordon AJ, Leslie DL, Sorbero M, Stein BD. Landis RK, et al. Drug Alcohol Depend. 2022 Dec 1;241:109669. doi: 10.1016/j.drugalcdep.2022.109669. Epub 2022 Oct 21. Drug Alcohol Depend. 2022. PMID: 36332589 Free PMC article.
Resident attitudes, experiences, and preferences on initiating buprenorphine in the emergency department: A national survey.
Yu MJ, Hawk K. Yu MJ, et al. AEM Educ Train. 2022 Jun 29;6(3):e10779. doi: 10.1002/aet2.10779. eCollection 2022 Jun. AEM Educ Train. 2022. PMID: 35784380 Free PMC article.
Impact of Policy Change on Access to Medication for Opioid Use Disorder in Primary Care.
Krupp J, Hung F, LaChapelle T, Yarrington ME, Link K, Choi Y, Chen H, Marais AD, Sachdeva N, Chakraborty H, McKellar MS. Krupp J, et al. South Med J. 2023 Apr;116(4):333-340. doi: 10.14423/SMJ.0000000000001544. South Med J. 2023. PMID: 37011580 Free PMC article.

See all "Cited by" articles

References

1. Increase in Fatal Drug Overdoses Across the United States Driven by Synthetic Opioids Before and During the COVID-19 Pandemic. Centers for Disease Control and Prevention. https://emergency.cdc.gov/han/2020/han00438.asp Accessed January 8, 2021.
1. D’Onofrio G., Venkatesh A.K., Hawk The adverse impact of COVID-19 on individuals with OUD highlights the urgent need for reform to leverage ED-based treatment. NEJM Catal Innov Care Deliv. 2020 doi: 10.1056/CAT.20.0190. - DOI
1. National Academies of Sciences, Engineering, and Medicine . The National Academies Press; 2019. Medications for Opioid Use Disorder Saves Lives. - DOI - PubMed
1. James K., Jordan A. The opioid crisis in Black communities. J Law Med Ethics. 2018;46:404–421. doi: 10.1177/1073110518782949. - DOI - PubMed
1. Kilaru A.S., Xiong A., Lowenstein M. Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients. JAMA Netw Open. 2020;3 doi: 10.1001/jamanetworkopen.2020.5852. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Increase in Fatal Drug Overdoses Across the United States Driven by Synthetic Opioids Before and During the COVID-19 Pandemic. Centers for Disease Control and Prevention. https://emergency.cdc.gov/han/2020/han00438.asp Accessed January 8, 2021.

[2] Increase in Fatal Drug Overdoses Across the United States Driven by Synthetic Opioids Before and During the COVID-19 Pandemic. Centers for Disease Control and Prevention. https://emergency.cdc.gov/han/2020/han00438.asp Accessed January 8, 2021.

[3] D’Onofrio G., Venkatesh A.K., Hawk The adverse impact of COVID-19 on individuals with OUD highlights the urgent need for reform to leverage ED-based treatment. NEJM Catal Innov Care Deliv. 2020 doi: 10.1056/CAT.20.0190. - DOI

[4] D’Onofrio G., Venkatesh A.K., Hawk The adverse impact of COVID-19 on individuals with OUD highlights the urgent need for reform to leverage ED-based treatment. NEJM Catal Innov Care Deliv. 2020 doi: 10.1056/CAT.20.0190. - DOI

[5] National Academies of Sciences, Engineering, and Medicine . The National Academies Press; 2019. Medications for Opioid Use Disorder Saves Lives. - DOI - PubMed

[6] National Academies of Sciences, Engineering, and Medicine . The National Academies Press; 2019. Medications for Opioid Use Disorder Saves Lives. - DOI - PubMed

[7] James K., Jordan A. The opioid crisis in Black communities. J Law Med Ethics. 2018;46:404–421. doi: 10.1177/1073110518782949. - DOI - PubMed

[8] James K., Jordan A. The opioid crisis in Black communities. J Law Med Ethics. 2018;46:404–421. doi: 10.1177/1073110518782949. - DOI - PubMed

[9] Kilaru A.S., Xiong A., Lowenstein M. Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients. JAMA Netw Open. 2020;3 doi: 10.1001/jamanetworkopen.2020.5852. - DOI - PMC - PubMed

[10] Kilaru A.S., Xiong A., Lowenstein M. Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients. JAMA Netw Open. 2020;3 doi: 10.1001/jamanetworkopen.2020.5852. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Improve Access to Care for Opioid Use Disorder: A Call to Eliminate the X-Waiver Requirement Now

Affiliations

Improve Access to Care for Opioid Use Disorder: A Call to Eliminate the X-Waiver Requirement Now

Authors

Affiliations

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous